419 related articles for article (PubMed ID: 6663592)
1. Immunochemical analyses of components of immune complexes in the sera of patients with autoimmune diseases.
Ferraccioli G; Karsh J; Osterland CK
J Rheumatol; 1983 Dec; 10(6):881-8. PubMed ID: 6663592
[TBL] [Abstract][Full Text] [Related]
2. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of six tests for circulating IgG complexes with special reference to IgM rheumatoid factors: analysis of systemic lupus erythematosus and rheumatoid arthritis series.
Wager O; Lindström P; Räsänen JA; Kekomäki R; Ziola B; Salmi A; Isomäki H; Skrifvars B; Penttinen K
Clin Exp Immunol; 1981 Oct; 46(1):149-60. PubMed ID: 7337967
[TBL] [Abstract][Full Text] [Related]
4. Quantitation and characterization of soluble immune complexes precipitated from sera by polyethylene glycol (PEG).
Chia D; Barnett EV; Yamagata J; Knutson D; Restivo C; Furst D
Clin Exp Immunol; 1979 Sep; 37(3):399-407. PubMed ID: 315842
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes and rheumatoid arthritis.
Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a disease specific antigen in circulating immune complexes in ankylosing spondylitis.
Bruneau C; Bonin H
Clin Exp Immunol; 1983 Sep; 53(3):529-35. PubMed ID: 6616954
[TBL] [Abstract][Full Text] [Related]
7. [Anti-fibronectin autoantibodies in systemic lupus erythematosus, rheumatoid polyarthritis, and various viral or bacterial infectious diseases].
Henane T; Rigal D; Monier JC
Pathol Biol (Paris); 1986 Mar; 34(3):165-71. PubMed ID: 3517785
[TBL] [Abstract][Full Text] [Related]
8. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid.
Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P
J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151
[TBL] [Abstract][Full Text] [Related]
9. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders.
Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P
Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033
[TBL] [Abstract][Full Text] [Related]
10. The specific detection of IgG, IgA and the complement components C3 and C4 in circulating immune complexes.
Valentijn RM; van Es LA; Daha MR
J Clin Lab Immunol; 1984 Jun; 14(2):81-6. PubMed ID: 6748050
[TBL] [Abstract][Full Text] [Related]
11. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
[TBL] [Abstract][Full Text] [Related]
12. Characterization of autoantibody activities in sera anti-DNA antibody and circulating immune complexes from 12 systemic lupus erythematosus patients.
Adyel FZ; Hentati B; Boulila A; Hachicha J; Ternynck T; Avrameas S; Ayadi H
J Clin Lab Anal; 1996; 10(6):451-7. PubMed ID: 8951619
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes and rheumatoid arthritis: the induction of immune complex formation between rheumatoid factor and IgG by polyethylene glycol.
Faaber P; van den Bersselaar LA; van de Putte L; van den Berg WB
J Rheumatol; 1989 Oct; 16(10):1304-9. PubMed ID: 2681758
[TBL] [Abstract][Full Text] [Related]
14. IgG subclasses of PEG precipitable IgG in systemic lupus erythematosus sera.
Morland C; Michael J; Adu D
Clin Nephrol; 1989 Apr; 31(4):204-9. PubMed ID: 2714025
[TBL] [Abstract][Full Text] [Related]
15. Potential pathogenicity of deglycosylated IgG cross reactive with streptokinase and fibronectin in the serum of patients with rheumatoid arthritis.
Cuchacovich M; Gatica H; Grigg DM; Pizzo SV; Gonzalez-Gronow M
J Rheumatol; 1996 Jan; 23(1):44-51. PubMed ID: 8838507
[TBL] [Abstract][Full Text] [Related]
16. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
[TBL] [Abstract][Full Text] [Related]
17. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
[TBL] [Abstract][Full Text] [Related]
18. Detection of immune complexes by a new assay, the polyethylene glycol precipitation-complement consumption test (PEG-CC).
Harkiss GD; Brown DL
Clin Exp Immunol; 1979 Apr; 36(1):117-29. PubMed ID: 111880
[TBL] [Abstract][Full Text] [Related]
19. Circulating immune complexes in patients with rheumatoid arthritis and the effect of penicillamine in vitro.
Crawhall JC
Clin Invest Med; 1984; 7(1):53-8. PubMed ID: 6723125
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of Clq binding activity by IgM rheumatoid factor.
Zilberfarb JL; Andrews BS; Young AC; Davis JS
J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]